Chemotherapy for Recurrent or Refractory Advanced Non-Small Cell Lung Cancer Peter M. Ellis Frances A. Shepherd Publication of the Non-Small Cell Lung Cancer (NSCLC) Collaborative Group metaanalysis in 1995 established…
Pharmacogenomics in Lung Cancer: Predictive Biomarkers for Chemotherapy Oliver Gautschi Philip C. Mack David R. Gandara Rafael Rosell Commonly used platinum-based chemotherapy regimens have shown comparable activity in randomized studies…
Chemotherapy for Advanced Non-Small Cell Lung Cancer Leora Horn Cesare Gridelli Corey Langer David H. Johnson Lung cancer is the leading cause of cancer-related mortality worldwide.1,2 In North America and…
Radiation Treatment-Related Lung Damage Zhongxing Liao Elizabeth L. Travis Ritsuko Komaki More than 50% of patients with lung cancer receive radiation during case management. Because treatment sometimes requires that a…
Stereotactic Techniques for Lung Cancer Treatment Robert D. Timmerman Timothy D. Solberg Brian D. Kavanagh Simon S. Lo Historically, the term stereotactic is related to the correlation of tumor target…
Radiotherapy for Locally Advanced Lung Cancer: Stages IIIA and IIIB Jason R. Pantarotto Suresh Senan THE SCOPE OF THE PROBLEM Lung cancer is the leading cause of cancer deaths in…
Biological Basis of Fractionation and Timing of Radiotherapy Dirk De Ruysscher Vincent S. Khoo Søren M. Bentzen THE BIOLOGY OF DOSE FRACTIONATION IN RADIOTHERAPY Radiation biology is the study of…
Physical Basis of Modern Radiotherapy: Dose and Volume Paul Keall José Belderbos Feng-Ming (Spring) Kong About 60% of cancer patients receive radiation therapy (RT),1 making radiation the most common “drug”…
Complications of Surgery for Lung Cancer Traves D. Crabtree Chadrick E. Denlinger BACKGROUND Surgery remains the primary therapy for patient with early stage non-small cell lung cancer. Nonsurgical modalities of…
Surgical Management of Small Cell Lung Cancer Theolyn Price Francis Nichols Small cell lung cancer (SCLC) is a virulent, rapidly growing, early metastasizing, invasive cancer. SCLC represents approximately 15% of…
